Kadmon Pharmaceuticals, LLC
Records under this name other than patents Kadmon Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Kadmon Pharmaceuticals, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,723,310 | Large Dose Ribavirin Formulations Formerly held In force · High confidence | In force | High confidence | |
| US 11,479,533 | Inhibitors of Rho associated coiled-coil containing protein kinase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,926,596 | Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase Formerly held In force · High confidence | In force | High confidence | |
| US 10,874,624 | Stable trientine formulations Lapsed on the fee record Ended Dec 29, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 29, 2024 | From the USPTO record |
| US 7,538,094 | Composition Containing Ribavirin and Use Thereof Lapsed on the fee record Ended May 26, 2021 · High confidence | Lapsed on the fee record | Ended May 26, 2021 | High confidence |
| US 6,720,000 | Process for Producing Wet Ribavirin Pellets Term ended Term ended Mar 19, 2021 · High confidence | Term ended | Term ended Mar 19, 2021 | High confidence |